glp-1 complementary offerings Beyond weight loss: Integrating RA therapies into psychological and behavioral care for obesity and binge eating disorder | Reviews in Endocrine and Metabolic Disorders Added Value to GLP-1 Receptor

A personalized genetic assessment may reveal whether you have genetic predispositions that favor GLP-1 monotherapy, alternative mechanisms, or heightened sensitivity to sympathomimetic effects

Once mast cell activation is identified as a key driver of neuroautoimmunity, the clinical objective shifts toward calming the immune system, restoring barrier integrity, and reducing inflammatory burden

For my differentiated thyroid cancer patients, I say, If you're obese, your metabolic health is going to cause more harm than an indolent thyroid cancer. There is research that shows that even if you slightly increase the thyroid cancer risk, you decrease the overall risk of all types of cancer if you reduce somebody's weight and get them to a metabolically healthier weight

This ensures the needle reaches the subcutaneous fat layer rather than depositing medication into the dermis (too shallow) or muscle (too deep)